Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yi'an Cold Capsule is a Traditional Chinese Medicine (TCM) developed by Zhangzhou Yian Pharmaceutical Co., Ltd. for the treatment of upper respiratory tract infections, specifically those characterized by Wind-Heat Syndrome. It is formulated as a capsule for oral administration. The drug was evaluated in a Phase 3 randomized, double-blind, placebo-controlled clinical trial (CTR20130241) to assess its safety and efficacy in alleviating symptoms associated with the common cold and upper respiratory infections. As a TCM product, it typically contains a proprietary blend of botanical extracts intended to clear heat, detoxify, and relieve exterior symptoms according to traditional medical principles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yi'an Cold Capsule.